# Hepatocyte growth factor in biosheets promotes autonomous regeneration of cutaneous tissue after transplantation onto a full-thickness skin defect

**Authors:** Keisuke Suzuki, Hiroko Komura, Ryo Konno, Yusuke Kawashima, Eiichiro Watanabe, Hiroki Sato, Kunio Matsumoto, Ryoko Inaki, Sanshiro Kanazawa, Yukiyo Asawa, Atsuhiko Hikita, Kazuto Hoshi, Jun Fujishiro, Makoto Komura

PMC · DOI: 10.1016/j.mtbio.2026.102969 · Materials Today Bio · 2026-02-25

## TL;DR

Biosheets containing hepatocyte growth factor (HGF) help regenerate skin tissue more effectively than fascia in mice.

## Contribution

The study identifies HGF as a key mediator in biosheet-induced skin regeneration through re-epithelialization and angiogenesis.

## Key findings

- Biosheets promote faster skin epithelialization compared to subcutaneous fascia in mouse models.
- HGF levels are significantly higher in biosheets and are essential for wound healing.
- Blocking HGF in biosheets impairs skin regeneration, confirming its role in the process.

## Abstract

Biosheets and biotubes are collagenous connective tissue membranes that surround unabsorbable molds embedded in living tissues, and can regenerate damaged tissues in various organs following in-situ transplantation. However, the mechanisms underlying tissue regeneration are still unclear. In this study, we analyzed the histological features and cellular composition in the biosheets, and observed dramatic time-dependent changes. We transplanted biosheets into full-thickness wounds in a mouse model, and evaluated skin regeneration through histological analysis in comparison with subcutaneous fascia transplantation. Our findings confirm that biosheets can accelerate epithelialization of skin wounds of mouse more effectively than fascia. To elucidate the mechanism underlying skin regeneration by biosheets, we compared the protein expression in the biosheets and subcutaneous fascia. Proteomics analysis revealed significant differences in the protein profiles of the biosheets and fascia, with marked elevation of hepatocyte growth factor (HGF) in the biosheets. Addition of HGF in situ accelerated angiogenesis and epithelial regeneration in the fascia-transplanted full-thickness wounds in mice. On the other hand, neutralization of HGF impaired the wound healing process following biosheet transplantation. In conclusion, our findings suggest that HGF mediates biosheet-mediated regeneration of cutaneous tissues by contributing to re-epithelialization and angiogenesis.

Image 1

•Biosheets have been investigated as scaffolds for cutaneous tissue regeneration.•Biosheets accelerated cutaneous regeneration in a mouse model.•Proteomic analysis of biosheets showed elevation of HGF, PDGF-β, TGF-β, and Cdk1.•Neutralization of HGF in biosheets by anti-HGF antibodies impaired cutaneous regeneration.

Biosheets have been investigated as scaffolds for cutaneous tissue regeneration.

Biosheets accelerated cutaneous regeneration in a mouse model.

Proteomic analysis of biosheets showed elevation of HGF, PDGF-β, TGF-β, and Cdk1.

Neutralization of HGF in biosheets by anti-HGF antibodies impaired cutaneous regeneration.

## Linked entities

- **Proteins:** HGF (hepatocyte growth factor), PDGFB (platelet derived growth factor subunit B), TGFB1 (transforming growth factor beta 1), CDK1 (cyclin dependent kinase 1)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Mcam (melanoma cell adhesion molecule) [NCBI Gene 84004] {aka 1-gicerin, CD146, CD149, Muc18, s-endo, s-gicerin}, Cdk1 (cyclin dependent kinase 1) [NCBI Gene 12534] {aka Cdc2, Cdc2a, p34<CDC2>}, HGF (hepatocyte growth factor) [NCBI Gene 3082] {aka DFNB39, F-TCF, HGFB, HPTA, SF}, THY1 (Thy-1 cell surface antigen) [NCBI Gene 7070] {aka CD90, CDw90}, alp (alopecia, recessive) [NCBI Gene 11691], Hgf (hepatocyte growth factor) [NCBI Gene 15234] {aka C230052L06Rik, HGF/SF, NK1, NK2, SF, SF/HGF}, Fn1 (fibronectin 1) [NCBI Gene 14268] {aka E330027I09, Fn, Fn-1}, Eng (endoglin) [NCBI Gene 13805] {aka CD105, Endo, S-endoglin}, HGF (hepatocyte growth factor) [NCBI Gene 282879], MET (MET proto-oncogene, receptor tyrosine kinase) [NCBI Gene 280855] {aka HGFR, c-met}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Apc (APC, WNT signaling pathway regulator) [NCBI Gene 11789] {aka CC1, Min, mAPC}, ATXN1 (ataxin 1) [NCBI Gene 6310] {aka ATX1, D6S504E, SCA1}, Cd44 (CD44 antigen) [NCBI Gene 12505] {aka HERMES, Ly-24, Pgp-1}, Nt5e (5' nucleotidase, ecto) [NCBI Gene 23959] {aka 2210401F01Rik, 5'-NT, CD73, NT, Nt5, eNT}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 407152] {aka cd45}, ITGAM (integrin subunit alpha M) [NCBI Gene 3684] {aka CD11B, CR3A, HNA-4, MAC-1, MAC1A, MO1A}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, Cd34 (CD34 antigen) [NCBI Gene 12490], Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Il10 (interleukin 10) [NCBI Gene 16153] {aka CSIF, If2a, Il-10}, ITGB1 (integrin subunit beta 1) [NCBI Gene 3688] {aka CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA}, Thy1 (thymus cell antigen 1, theta) [NCBI Gene 21838] {aka CD90, T25, Thy-1, Thy-1.2, Thy1.1, Thy1.2}, ARHGEF3 (Rho guanine nucleotide exchange factor 3) [NCBI Gene 50650] {aka GEF3, STA3, XPLN}, Itgb1 (integrin beta 1 (fibronectin receptor beta)) [NCBI Gene 16412] {aka 4633401G24Rik, CD29, Fnrb, Gm9863, gpIIa}, Ly6a (lymphocyte antigen 6 family member A) [NCBI Gene 110454] {aka Ly-6A.2, Ly-6A/E, Ly-6E.1, Sca-1, Sca1, TAP}, Nanog (Nanog homeobox) [NCBI Gene 71950] {aka 2410002E02Rik, ENK, Stm1, ecat4}, Vwf (Von Willebrand factor) [NCBI Gene 22371] {aka 6820430P06Rik, B130011O06Rik, C630030D09, F8VWF, VWD}, ALB (albumin) [NCBI Gene 280717], Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Pdgfb (platelet derived growth factor subunit B) [NCBI Gene 18591] {aka PDGF-2, PDGF-B, Sis, c-sis}
- **Diseases:** burns (MESH:D002056), spinal cord injury (MESH:D013119), junctional epidermolysis bullosa (MESH:D016109), hindlimb ischemia (MESH:D007511), congenital cutaneous diseases (MESH:D030342), lung injury (MESH:D055370), graft-versus-host disease (MESH:D006086), diabetes (MESH:D003920), cancer (MESH:D009369), skin disorders (MESH:D012871), ischemic pain (MESH:D010146), fibrosis (MESH:D005355), fibrotic diseases (MESH:D004194), injury (MESH:D014947), inflammation (MESH:D007249), skin defect (MESH:D012868), iBTA (MESH:D017695), multiple sclerosis (MESH:D009103), tracheal defect (MESH:D014133), ulcer (MESH:D014456), immune-related (MESH:D007154), Crohn's disease (MESH:D003424), myocardial infarction (MESH:D009203), infections (MESH:D007239), giant nevi (MESH:D009506), tracheal stenosis (MESH:D014135), diabetic foot ulcers (MESH:D017719)
- **Chemicals:** Epon 812 (MESH:C004875), ethanol (MESH:D000431), TB (MESH:D014048), ACN (MESH:C084683), sodium dodecyl sulfate (MESH:D012967), silicone (MESH:D012828), iodoacetamide (MESH:D007460), isoflurane (MESH:D007530), cacodylate (MESH:D002101), water (MESH:D014867), C (MESH:D002244), acetonitrile (MESH:C032159), FITC (MESH:D016650), osmium tetroxide (MESH:D009993), tris(2-carboxyethyl)phosphine) (MESH:C080938), formic acid (MESH:C030544), P (MESH:D010758), OCT (MESH:C051883), calcium (MESH:D002118), formaldehyde (MESH:D005557), DAPI (MESH:C007293), polyurethane (MESH:D011140), DAB (MESH:C000469), eosin (MESH:D004801), glutaraldehyde (MESH:D005976), PBS (MESH:D007854), Sepharose (MESH:D012685), zirconia (MESH:C028541), paraformaldehyde (MESH:C003043), cysteine (MESH:D003545), CO2 (MESH:D002245), DIA (MESH:C076868), epoxy resin (MESH:D004853), Alexa Fluor488 (MESH:C000711379), uranyl acetate (MESH:C005460), TFA (MESH:D014269), hematoxylin (MESH:D006416), SO (MESH:C009195), S. (MESH:D013455), Alizarin (MESH:C010078), hydrogen peroxide (MESH:D006861), C-28009 (-), Silicon (MESH:D012825)
- **Species:** Canis lupus familiaris (dog, subspecies) [taxon 9615], Mus musculus (house mouse, species) [taxon 10090], Musculus (genus) [taxon 112137], Oryctolagus cuniculus (domestic rabbit, species) [taxon 9986], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Mutations:** T9300A
- **Cell lines:** /6J — Homo sapiens (Human), Cutaneous melanoma, Cancer cell line (CVCL_W797), Abcam — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_B1TE), C57BL6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), C57BL/6J — Mus musculus (Mouse), Transformed cell line (CVCL_C0MW), Chinese — Homo sapiens (Human), Adult hepatocellular carcinoma, Cancer cell line (CVCL_RH12)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12969807/full.md

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12969807/full.md

## References

91 references — full list in the complete paper: https://tomesphere.com/paper/PMC12969807/full.md

---
Source: https://tomesphere.com/paper/PMC12969807